These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 38168093)
1. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093 [TBL] [Abstract][Full Text] [Related]
2. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases. Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123 [TBL] [Abstract][Full Text] [Related]
3. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases. Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion]. Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748 [No Abstract] [Full Text] [Related]
5. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype. Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533 [TBL] [Abstract][Full Text] [Related]
6. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270 [TBL] [Abstract][Full Text] [Related]
7. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas. Fanburg-Smith JC; Smith JD; Flemming DJ Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130 [TBL] [Abstract][Full Text] [Related]
8. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960 [TBL] [Abstract][Full Text] [Related]
9. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2. Hiemenz MC; Kaur J; Kuang Z; Huang RSP; Harries L; Metzger D; Schiavone K; Millis SZ; Lin DI; Lechpammer M; Decker B; Mata DA; Reddy A; Parke M; Lee EY; Cui X; Iwenofu OH; Buehler D; Henderson L; Baldwin EM; Boikos SA; Ramkissoon SH; Smith SC Genes Chromosomes Cancer; 2023 Aug; 62(8):460-470. PubMed ID: 36862145 [TBL] [Abstract][Full Text] [Related]
10. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome. Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma. Csizmok V; Grisdale CJ; Williamson LM; Lim HJ; Lee L; Renouf DJ; Jones SJM; Marra MA; Laskin J; Smrke A Genes Chromosomes Cancer; 2024 Sep; 63(9):e23259. PubMed ID: 39302072 [TBL] [Abstract][Full Text] [Related]
12. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior. Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma. Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378 [TBL] [Abstract][Full Text] [Related]
14. Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging Brcic I; Scheipl S; Bergovec M; Leithner A; Szkandera J; Sotlar K; Suda AJ; Smolle MA; Kraus T; Rosenberg AE; Liegl-Atzwanger B; Igrec J Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555836 [TBL] [Abstract][Full Text] [Related]
15. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing. Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853 [TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma With Zhong P; Wei S; Xiao H; Zeng Y Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350 [TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma With Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645 [TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review. Gallagher KPD; Roza ALOC; Tager EMJR; Mariz BALA; Soares CD; Rocha AC; Abrahão AC; Romañach MJ; Carlos R; Hunter KD; Lopes MA; Vargas PA; Santos-Silva AR Head Neck Pathol; 2023 Jun; 17(2):546-561. PubMed ID: 36374445 [TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma. Li BX; David LL; Davis LE; Xiao X J Biol Chem; 2022 Oct; 298(10):102434. PubMed ID: 36041632 [TBL] [Abstract][Full Text] [Related]
20. A novel FUS::NFATC4 fusion detected in a sarcoma with morphological features overlapping with NFATC2 sarcomas. Klubíčková N; Gross JM; Comová K; Kuruc J; Michal M Histopathology; 2024 Jan; 84(2):413-415. PubMed ID: 37813649 [No Abstract] [Full Text] [Related] [Next] [New Search]